China Universal Asset Management Company’s Rigel Pharmaceuticals RIGL Stock Holding History

China Universal Asset Management Company’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$87.1K	Buy	3,221 +263	+9%	+$8.84K	0.01%	419
2025 Q4	$127K	Sell	2,958 -186	-6%	-$7.01K	0.01%	391
2025 Q3	$89.1K	Sell	3,144 -446	-12%	-$13.3K	0.01%	396
2025 Q2	$67.2K	Buy	3,590 +57	+2%	+$1.08K	0.01%	394
2025 Q1	$63.6K	Sell	3,533 -202	-5%	-$4.1K	0.01%	395
2024 Q4	$62.8K	Buy	+3,735	New	+$71.6K	0.01%	437
2022 Q4	–	Sell	-162	Closed	-$2K	–	450
2022 Q3	$2K	Buy	+162	New	+$2.19K	﹤0.01%	356

Other funds holding RIGL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

China Universal Asset Management Company's RIGL Position: Q1 2026 in Review

China Universal Asset Management Company increased its Rigel Pharmaceuticals (RIGL) stake by 8.9% in Q1 2026, buying an estimated $8.84K and bringing the position to 3,221 shares worth $87.1K. The position accounts for 0.01% of the portfolio, ranked #419.

China Universal Asset Management Company first reported a position in RIGL in Q3 2022 and has held it in 7 quarters since. The position peaked at $127K in Q4 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

China Universal Asset Management Company held 3,221 shares of Rigel Pharmaceuticals worth $87.1K as of Q1 2026.
China Universal Asset Management Company bought 263 Rigel Pharmaceuticals shares in Q1 2026, an estimated $8.84K.
Rigel Pharmaceuticals made up 0.01% of China Universal Asset Management Company's portfolio in Q1 2026, its #419 holding.
China Universal Asset Management Company first reported a position in Rigel Pharmaceuticals in Q3 2022 and has held it in 7 quarters since.
China Universal Asset Management Company's Rigel Pharmaceuticals position peaked at $127K in Q4 2025.
159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.